Not finding it? Sign in to also search OpenAlex live.
-
Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies2021 International Journal of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access
Joao Gorgulho, Christoph Roderburg, Felix Heymann, Maximilian Franz Schulze-Hagen, Fabian Beier, Mihael Vucur, +6 more
33citations -
Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
Kirsi Marjaana Manz, Jeanette Bahr, Till Ittermann, Konstanze Döhner, Steffen Koschmieder, Tim H. Brümmendorf, +4 more
5citations -
Molecular characterization of patients (pts) with myeloproliferative neoplasms treated with INCA033989 demonstrates selective targeting of CALR mutant hematopoietic cells2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Bethan Psaila, Jyoti Nangalia, Jason R. Gotlib, Claire N. Harrison, John O Mascarenhas, Erin Lynn Crowgey, +1 more
4citations -
Bound states in microwave QED: Crossover from waveguide to cavity regime2022 arXiv (Cornell University) preprint Computer Science Quantum Information and Cryptography Open access
N. Pradeep Kumar, Andrés Rosario Hamann, Rohit Navarathna, Maximilian Zanner, Mikhail Pletyukhov, Arkady Fedorov
0citations